David Clair | Vice President, Investor Relations and Corporate Development |
Chuck Kummeth | Chief Executive Officer |
Jim Hippel | Chief Financial Officer |
Puneet Souda | SVB Securities |
Jacob Johnson | Stephens |
Dan Arias | Stifel |
Catherine Schulte | Baird |
Alex Nowak | Craig-Hallum |
Patrick Donnelly | Citi |
Paul Knight | KeyBanc |
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2022. At this time, all participants have been placed in a listen-only mode and the call will be opened for questions following management's prepared remarks.
During our Q&A session, please limit yourself to one question and a follow-up. I would now like to turn the call over to David Clair, Bio-Techne's Vice President, Investor Relations and Corporate Development. Please go ahead.